High-dose Botulinum Toxin Therapy: Safety, Benefit, and Endurance of Efficacy
By: Shannon Y. Chiu, Bhavana Patel, Matthew R. Burns, Joseph Legacy, Aparna Wagle Shukla, Adolfo Ramirez-Zamora, Wissam Deeb and Irene A. Malaty
Open Access
|Feb 2020Authors
Shannon Y. Chiu
Shannon.chiu@neurology.ufl.edu
Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL
Bhavana Patel
Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL
Matthew R. Burns
Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL
Joseph Legacy
Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL
Aparna Wagle Shukla
Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL
Adolfo Ramirez-Zamora
Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL
Wissam Deeb
Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL
Irene A. Malaty
Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL
DOI: https://doi.org/10.5334/tohm.527 | Journal eISSN: 2160-8288
Language: English
Submitted on: Nov 23, 2019
Accepted on: Jan 15, 2020
Published on: Feb 27, 2020
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2020 Shannon Y. Chiu, Bhavana Patel, Matthew R. Burns, Joseph Legacy, Aparna Wagle Shukla, Adolfo Ramirez-Zamora, Wissam Deeb, Irene A. Malaty, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.